期刊文献+

地塞米松对肺癌细胞株A549生长及化疗作用 被引量:6

The study of the impact of dexasone and observe affecting the expression of protein P53 and P-Glycoprotein on pulmonary adenocarcinoma cell A549
下载PDF
导出
摘要 【目的】观察地塞米松对肺腺癌细胞生长及与化疗作用的影响并探讨其与凋亡相关基因突变型p53及耐药P糖蛋白(P-glycoprotein,P-gp)表达相关性。【方法】将不同浓度的地塞米松单独或与长春新碱(VCR)联合作用于肺腺癌细胞株A549。四唑盐(MTT)试验测定药物对肺腺癌细胞A549的抑制率,筛选出药物的IC50浓度。免疫组化法测定IC50浓度各药物应用对p53、P糖蛋白(P-gp)表达的影响,比较二者的相关性。【结果】不同浓度的地塞米松对肿瘤的生长及化疗有影响,且上述药物与IC50浓度的VCR联合应用时能增加VCR的抑制率,用药后各组p53、P-gp表达均减少(P<0.01),且二者表达呈正相关。【结论】地塞米松对A549细胞的生长及化疗有影响,其机制可能与凋亡相关基因p53及P-gp介导的肺癌耐药机制有关。 [Objective] To observe the impact of dexasone on the growth of pulmonary adenocarcinoma cell A549. Furthermore to study the influence is dued to affecting the expression of the two protein p53 and P-Glycoprotein (P-gp). [Methods] To place different concentration of dexasone on A549 cell alone or combinated with xincristine (VCR). MTF assay (mononuclear cell direct cytoxicity assay) : to estimate the antirate of those medicine on A549 cell, screening the concentration of IC50 in those medicine. Immunohistology chemistry Technique (IHC) To determinate the influence of those medicine, which with xincristine (VCR) of IC50, on the expression of p53 and P-gp , moreover compare the correlation of the two protein. [Results] dexasone all have effect on the growth of A549 cell. IC50 concentration on A549 cell make significantly change of the expression of p53 and P-gp, all is decreased/decereaced (P 〈 0.01 ) and the expression of p53 is positively correlated. [Conclusions] The result show that dexasome can have an effect on the growth of tumor in vitro, which make clear that p53 and P-gp may be involved in the pathways of multidrug resistance.
出处 《武警医学院学报》 CAS 2009年第3期216-218,233,共4页 Acta Academiae Medicinae CPAPF
关键词 地塞米松 肺腺癌细胞株 P53 P糖蛋白 Dexasone Lung adenocarcinomal cell strain p53 P-glycoprotein
  • 相关文献

参考文献8

二级参考文献30

  • 1Beahrs OH. Staging of cancer of the colon and rectum [J]. Cancer, 1992,70 (5): 1393.
  • 2Gottesman MM,Pastan I. Biochemistry of multidrug resistance mediated by the multidrug transporter[J ]. Annu Rev Biochem, 1993,62 (1): 385.
  • 3Weinstein RS,Jakate SM, Dominguez JM, et al. Relationship of the expression of the multidrug resistance gene product (p-glycoprotein) in human colon carcinoma to local tumor aggressiveness and lymph node metastasis[J]. Cancer Res, 1991,51(10) :2720.
  • 4Sutoh I, Kohno H, Nakashima Y, et al. Concurrent expressions of metallothionein, glutathione-s-transferaseπ,and p-glycoprotein in colorectal cancers[J ]. Dis Colon Rectun, 2000,43 (2): 221.
  • 5Tokunaga Y, Hosogi H, Hoppou T, et al. Effects of MDR1/p-glycoprotein expression on prognosis in advanced colorectal cancer after surgery [J ]. Oncol Rep,2001,8(4) :815.
  • 6Morse MA. The role of glutathione-S-transferase pi in colorectal cancer: friend or foe? [ J ]. Gastroenterology,2001,121(4): 1010.
  • 7Dogru-Abbasoglu S, Mutlu-Turkoglu U,Turkoglu S,et al. Glutathione-s-transferase pi in malignant tissues and plasma of human colorectal and gastric cancers [J ]. J Cancer Res Clin Oncol,2002,128(2):91.
  • 8Schneider E, Hsiang YH, Liu LF. DNA topoisomerases as anticancer drug targets[J ]. Adv Pharmacol, 1990,21(2): 149.
  • 9Nakopoulou L, Zervas A, Lazaris AC, et al. Predictive value of topoisomerase Ⅱ alpha immunostaining in urothelial bladder carcinoma [J ]. J Clin Pathol, 2001,54(4): 309.
  • 10Peters G J, Wilt CL, Triest B, et al. Thymidylate synthase and drug resistance[J ]. Eur J Cancer, 1995,31A(7~ 8): 1299.

共引文献22

同被引文献66

  • 1陈玉霞,李宗斌,刁飞,王燕,卢建.地塞米松抑制人卵巢癌细胞HO-8910增殖的分子机制:RhoB信号通路的作用[J].中华医学杂志,2006,86(20):1400-1404. 被引量:13
  • 2姜桂林.奥沙利铂联合氟脲嘧腚/醛氢叶酸双周疗法治疗晚期大肠癌临床观察[J].中国肿瘤临床,2006,33(18):1067-1068. 被引量:3
  • 3Goke MN, Schneider M, Bell W, et al. Differential glucocorticoid effects on repair mechanisms and NF-kappaB activity in the intestinal epithefium[J]. Regul Pept, 2002, 105(3): 203-214.
  • 4Alford TC, Do HM, Geelhoed GW, et al. Steroid hormone receptors in human colon cancers[J]. Cancer, 1979, 43(3): 980-984.
  • 5Li Z, Chen Y, Cao D, et al. Glucocorticoid up-regnlates transforming growth factor-beta (TGF-beta) type II receptor and enhances TGF-beta signaling in human prostate cancer PC-3 cells [J]. Endocrinology, 2006, 147(11): 5259-5267.
  • 6Yano A, Fujii Y, Iwai A, et al. Glucocorficoids suppress tumor angiogenesis and in vivo growth of prostate cancer cells[J]. Clin Cancer Res, 2006, 12(10): 3003-3009.
  • 7Yemelyanov A, CzwomogJ, Gera L, et al. Novel steroid receptor phyto-modulator compound a inhibits growth and survival of prostate cancer cells[J]. Cancer Res, 2008, 68(12): 4763-4773.
  • 8Melhem A, Yamada SD, Fleming GF, et al. Administration of glucocorticoids to ovarian cancer patients is associated with expression of the anti-apoptotic genes SGK1 and MKP1/DUSP1 in ovarian tissues[J].Clin Cancer Res, 2009, 15(9): 3196-3204.
  • 9Zhang C, Kolb A, Mattern J, et al. Dexamethasone desensitizes hepatocellular and colorectal turnouts toward cytotoxic therapy [J]. Cancer Lett, 2006, 242(1): 104-111.
  • 10Wang H, Li M, Rinehart JJ, et al. Pretreatment with dexamethasone increases antitumor activity of carboplatin and gemcitabine ha mice bearing human cancer xenografts: in vivo activity, pharmacokinetics, and clinical implications for cancer chemotherapy[J].Clin Cancer Res, 2004, 10(5): 1633-1644.

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部